Investing.com investing.com 08 Jan, 2021 08:30 am

Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study By Reuters

Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study By Reuters
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study

Coronavirus 5 hours ago (Jan 07, 2021 10:35PM ET) By Michael Erman NEW YORK (Reuters) - Pfizer Inc (NYSE: PFE ) and BioNTech's COVID-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in the UK and South Africa, according to a laboratory study conducted by the U.Its findings are limited, because it does not look at the full set of mutations found in either of the new variants of the rapidly spreading virus.Scientists have expressed concern that vaccines being rolled out may not be able to protect against the new variants, particularly the one that emerged in South Africa.Simon Clarke, an associate professor in cellular microbiology at the University of Reading, said this week that while both variants had some new features in common, the one found in South Africa "has a number additional mutations" that included more extensive alterations to the spike protein.

The study was conducted on blood taken from people who had been given the vaccine.The Pfizer/BioNTech vaccine and the one from Moderna (NASDAQ: MRNA ) Inc, which use synthetic messenger RNA technology, can be quickly tweaked to address new mutations of a virus if necessary.

Read full story at investing.com